-+ 0.00%
-+ 0.00%
-+ 0.00%

Shanghai Pharmaceutical (601607.SH): Omeprazole sodium bicarbonate dry suspension (I) approved for production

Zhitongcaijing·08/03/2026 07:57:01
Listen to the news

Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) issued an announcement. Recently, Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd. (“Shangyao Xinyi”), a subsidiary of the company, received the “Drug Registration Certificate” (certificate number: 2026S02750) for omeprazole sodium bicarbonate dry suspension (I) issued by the State Drug Administration, and the drug was approved for production.

Omeprazole sodium bicarbonate dry suspension (I) (containing omeprazole 20 mg and sodium bicarbonate 1680 mg per bag) is mainly used for short-term treatment of active duodenal ulcers and gastroesophageal reflux disease.